EUVIMEDEUVIMED entdecken
Crossref

Light‐Triggered Nitric Oxide Nanogenerator with High l ‐Arginine Loading for Synergistic Photodynamic/Gas/Photothermal Therapy

Hui Shi, Cheng-Feng Xiong, Lin-Jun Zhang, Hu-Chen Cao, Ru Wang, Pei Pan, Hai-Yan Guo, Tao Liu iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202300012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Hui Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China. Hauptthemen laut MEDLINE: Photochemotherapy, Nanoparticles. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of nanomedicines that combine photothermal therapy (PTT) with photodynamic therapy (PDT) is considered promising for cancer treatment, but still faces the challenge of enhancing tumoricidal efficiency. Fortunately, apart from the well‐acknowledged effect on direct tumor cell‐killing, nitric oxide (NO) is also considered to be effective for the enhancement of both PTT and PDT. However, both the low loading efficiency of NO precursor and the short half‐life time and diffusion distance of NO hamper the synergistic therapeutic efficacy of NO. Taking the aforementioned factors into account, a mitochondria‐targeted nitric oxide nanogenerator, EArgFe@Ce6, is constructed to achieve high loading of the NO donor l ‐Arginine ( l ‐Arg) for synergistic photodynamic/gas/photothermal therapy upon single 660 nm light irradiation. The coordination of epigallocatechin gallate (EGCG) and ferric ions (Fe 3+ ) provides EArgFe@Ce6 supreme photothermal capability to perform low‐temperature PTT (mPTT). EGCG endows EArgFe@Ce6 with mitochondria‐targeting capability and meanwhile favors hypoxia alleviation for enhanced PDT. The PDT‐produced massive reactive oxygen species (ROS) further catalyzes l ‐Arg to generate a considerable amount of NO to perform gas therapy and sensitize both mPTT and PDT. In vitro and in vivo studies demonstrate that the synergistic photodynamic/gas/photothermal therapy triggered by single 660 nm light irradiation is highly effective for tumor treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNanoparticlesPhotosensitizing AgentsNitric OxidePhotothermal TherapyPhototherapyCell Line, Tumor

Stichwörter der Autor:innen

L-argininemetal-polyphenol coordinationnitric oxide therapypolyphenol assemblysynergistic cancer therapy

Substanzen

Photosensitizing AgentsNitric Oxide

Autor:innen und Institutionen

  • School of Biomedical Engineering, Anhui Medical University, Hefei, 230032, P. R. China.
  • School of Pharmacy, Anhui Medical University, Hefei, 230032, P. R. China.
  • School of Public Health, Anhui Medical University, Hefei, 230032, P. R. China.

ORCID-Profile: Tao Liu

Förderung

  • National Natural Science Foundation of China
  • Anhui Medical University

Zitieren

APA

Shi, H., Xiong, C. F., Zhang, L. J., Cao, H. C., Wang, R., Pan, P., Guo, H. Y., & Liu, T. (2023). Light‐Triggered Nitric Oxide Nanogenerator with High l ‐Arginine Loading for Synergistic Photodynamic/Gas/Photothermal Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300012

Vancouver

Shi H, Xiong CF, Zhang LJ, Cao HC, Wang R, Pan P, et al. Light‐Triggered Nitric Oxide Nanogenerator with High l ‐Arginine Loading for Synergistic Photodynamic/Gas/Photothermal Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300012

BibTeX
@article{Shi2023,
  author = {Shi, Hui and Xiong, Cheng-Feng and Zhang, Lin-Jun and Cao, Hu-Chen and Wang, Ru and Pan, Pei and Guo, Hai-Yan and Liu, Tao},
  title = {Light‐Triggered Nitric Oxide Nanogenerator with High l ‐Arginine Loading for Synergistic Photodynamic/Gas/Photothermal Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202300012}
}
Kostenlos starten →